Package Leaflet: Information for the User
Tamsulosina Almus 0.4 mg prolonged-release tablets EFG
Tamsulosine hydrochloride
Read the package leaflet carefully before starting to take the medicine, as it contains important information for you.
Contents of the package leaflet
Tamsulosin relaxes the muscles in the prostate and urinary tract. By relaxing the muscles, tamsulosin allows urine to flow more easily and facilitates urination. It also reduces the feeling of urgency.
Tamsulosin is used in men to relieve urinary symptoms caused by an enlarged prostate (benign prostatic hyperplasia). These symptoms may include difficulty urinating (weak stream), dribbling, urgency, and frequent need to urinate both at night and during the day.
Do not take Tamsulosina Almus if:
Warnings and precautions
Be particularly careful withTamsulosina Almusif:
Regular medical check-ups are necessary to monitor the development of the disease for which you are being treated.
You may observe remains of tablets in your stool. Since the active substance of the tablet has already been released, there is no risk that the tablet will be less effective.
Using Tamsulosina Almus with other medicines
Tell your doctor or pharmacistif you are using or have recently used other medicines, including those obtained without a prescription.
Other medicines may be affected by tamsulosin. These medicines, in turn, may affect the proper functioning of tamsulosin. Tamsulosin may interact with:
TakingTamsulosina Almuswith food and drinks
Tamsulosin can be taken independently of meals.
Driving and using machines
There is no evidence that tamsulosin affects the ability to drive and use machines. However, you should be aware that tamsulosin may cause dizziness. Only drive or operate machines if you feel well.
Follow the instructions for administration of Tamsulosina Almus indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
The normal doseis 1 tablet per day. You can take tamsulosin with or without food, preferably at the same time each day.
The tablet should be swallowed whole. It is important not to break or chew the tablet, as this may affect the proper functioning of tamsulosin.
Tamsulosin is not indicated for children.
If you take moreTamsulosina Almusthan you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount ingested.
If you take more tamsulosin than you should, your blood pressure may drop suddenly. You may experience dizziness, weakness, vomiting, diarrhea, and fainting. Lie down to minimize the effects of low blood pressure and consult your doctor.
If you forget to takeTamsulosina Almus
If you have forgotten to take Tamsulosina Almus as recommended, you can take your dose later on the same day. If you have missed a dose for one day, take the next dose at the usual time. Do not take a double dose to make up for the missed doses.
If you stop takingTamsulosina Almus
When treatment with tamsulosin is discontinued prematurely, your original symptoms may return. Therefore, take Tamsulosina Almus for the entire time your doctor prescribes it, even if your symptoms have disappeared. Always consult your doctor if you decide to stop treatment.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Tamsulosina Almus can cause side effects, although not everyone gets them.
It is rare for serious side effects to occur. Contact your doctor immediatelyif you experience a severe allergic reaction that causes swelling of the face or throat(angioedema).
Common(may affect up to 1 in 10 patients):
Dizziness • Abnormal ejaculation.
Uncommon(may affect up to 1 in 100 patients):
Headache • Heartbeat perceptible (palpitations) • Reduction of blood pressure when standing up, which causes dizziness or fainting (orthostatic hypotension) • Swelling and irritation in the nose (rhinitis) • Constipation • Diarrhea • Nausea • Vomiting • Rash • Hives (urticaria) • Feeling of weakness (asthenia).
Rare(may affect up to 1 in 1,000 patients):
Fainting (syncope).
Very rare(may affect up to 1 in 10,000 patients):
Painful erection (priapism) • Severe skin condition with blisters on the skin, mouth, eyes, and genitals (Stevens-Johnson syndrome).
Frequency not known(cannot be estimated from the available data):
Abnormal heart rhythm • Irregular heartbeat • Faster heartbeat • Difficulty breathing • Dry mouth.
During eye surgery, a condition called Intraoperative Floppy Iris Syndrome (IFIS) may occur: the pupil may not dilate properly, and the iris (the colored part of the eye) may become floppy during surgery. For more information, see section 2, Be particularly careful.
If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet.
Reporting side effects:
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Store in the original package to protect from light.
Do not use Tamsulosina Almus after the expiry date stated on the package after "EXP". The expiry date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Deposit the packages and medicines you no longer need at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of packages and medicines you no longer need. This will help protect the environment.
Composition of Tamsulosina Almus 0.4 mg
Appearance of the product and package contents
Tamsulosina Almus is presented in the form of round, white tablets with the inscription "T9SL" on one side and "0.4" on the other.
They are available in packages of 10, 18, 20, 28, 30, 50, 60, 90, 98, and 100 tablets.
Not all package sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder:
Almus Farmacéutica, S.A.U.
Marie Curie, 54
08840 Viladecans (Barcelona), Spain
Telephone: 93 739 71 80
Email: farmacovigilancia@almusfarmaceutica.es
Manufacturer:
Synthon Hispania, S.L.
Castello, 1
Polígono Las Salinas
08830 Sant Boi de Llobregat
Spain
Synthon BV
Microweg 22,
6545 CM Nijmegen
Netherlands
Date of the last revision of this package leaflet:December 2013
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
The average price of TAMSULOSIN ALMUS 0.4 mg PROLONGED-RELEASE TABLETS in October, 2025 is around 10.96 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.